<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="72207">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01936142</url>
  </required_header>
  <id_info>
    <org_study_id>TASMC-13-0167-YMICH</org_study_id>
    <nct_id>NCT01936142</nct_id>
  </id_info>
  <brief_title>The Use of Renal Guard System in Patients Undergoing CRT Implantation</brief_title>
  <official_title>The Effect of Forced Diuresis With Matched Hydration in Reducing Acute Kidney Injury During CRT Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <authority>Israel: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the use of RenalGuard system which creates
      high urine output with fluid balancing may prevent contrast induced nephropathy in patient
      undergoing cardiac resynchronization therapy (CRT) implantation.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Change in Renal function</measure>
    <time_frame>24 and 48 hours post implantation and 8-11 days post implantation, 6 month post implantaion</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Change in Renal function will be measured by change in serum creatinine (mg/dl)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Left ventricular lead implantation success</measure>
    <time_frame>1 day post implantation</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Mortality</measure>
    <time_frame>6 month</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Hospitalization due to infection</measure>
    <time_frame>6 month</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>No RenalGuard</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group will undergo CRT implantation without using RenalGuard</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RenalGuard</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of the RenalGuard system during CRT implantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Use of RenalGuard</intervention_name>
    <arm_group_label>RenalGuard</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. eligible for CRT implantation

          2. estimated GFR &lt; 60ml/min/1.73m2

        Exclusion Criteria:

          1. On Dialysis

          2. Sensitivity to Furosemide

          3. Contraindication for urinary catheter

          4. Pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yoav Michowich, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tel Aviv Sourasky MC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tel Aviv Souraky MC</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yoav Michowich, MD</last_name>
      <phone>972-52-4266064</phone>
      <email>yoavm@tlvmc.gov.il</email>
    </contact>
    <investigator>
      <last_name>Yoav Michowich, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 4, 2013</lastchanged_date>
  <firstreceived_date>August 22, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tel-Aviv Sourasky Medical Center</investigator_affiliation>
    <investigator_full_name>Michal Roll PhD,MBA</investigator_full_name>
    <investigator_title>Head of Research and Development Division</investigator_title>
  </responsible_party>
  <keyword>Resynchroniztion therapy</keyword>
  <keyword>Kidney</keyword>
  <keyword>Contrast media</keyword>
  <keyword>Prevention</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
